28 декабря 2020 года, 15:00
Address: Информационное агентство ТАСС



Bristol Myers Squibb is the company of breakthroughs – the kind that transform patients` lives. Dedicated to our mission of discovering, developing and delivering life-saving innovations that help patients prevail over serious diseases, we`ll never give up our search for more hope, for more people, around the world.

We focus on innovations, as we believe in the power of science to address some of the most challenging diseases of our time. We have a history of scientific excellence, transforming patient outcomes in major diseases such as cancer, cardiovascular disease, HIV and HCV. We pioneered a class of medicines that harnesses the power of the immune system to treat cancer.

Generating new ideas and thinking differently are at the heart of everything we do for patients. We are driven by the knowledge that our efforts can make the difference for a patient.

Alisa Dzhangiryants
Director of Market Access & Pricing Department Bristol Myers Squibb

Alisa Dzhangiryants has been working in the pharmaceutical market for over 18 years. She joined Bristol-Myers Squibb in 2012 as a Project Manager for Immunology & Oncology. In 2014, she moved to the position of the Head of the group of Regional Market Access Managers.

Since 2017, he has been the Director of Market Access and Pricing Department.

Alisa graduated from the First Moscow State Medical University named after I. M. Sechenov with a PhD in Pharmaceutical Sciences.